ZD (Ziff Davis, Inc. Common Stock) Stock Analysis - Financials

Ziff Davis, Inc. Common Stock (ZD) is a publicly traded Communication Services sector company. As of May 21, 2026, ZD trades at $42.41 with a market cap of $1.52B and a P/E ratio of 29.73. ZD moved +1.00% today. Year to date, ZD is +25.24%; over the trailing twelve months it is +29.33%. Its 52-week range spans $22.45 to $60.62. Analyst consensus is buy with an average price target of $49.29. Rallies surfaces ZD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ZD's key financials?

ZD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ZD recently traded at $42.41. Market cap is $1.52B. P/E ratio is 29.73. Revenue is $1.40B.

ZD Key Metrics

Key financial metrics for ZD
MetricValue
Price$42.41
Market Cap$1.52B
P/E Ratio29.73
EPS$1.42
Dividend Yield0.46%
52-Week High$60.62
52-Week Low$22.45
Volume0
Avg Volume0
Revenue (TTM)$1.40B
Net Income$63.05M
Gross Margin85.71%

ZD Annual Financials

YearRevenueNet IncomeEPS
2024$1.40B$63.05M$1.42
2023$1.36B$41.50M$0.89
2022$1.39B$63.76M$1.36
2021$1.42B$496.71M$10.81

Latest ZD News

Recent ZD Insider Trades

  • FAY SARAH ANN bought 1.35K (~$49.95K) on Sep 15, 2025.
  • KRETZMER W BRIAN bought 653 (~$25.03K) on Mar 6, 2025.
  • RICHTER BRET bought 2.50K (~$98.03K) on Mar 5, 2025.

ZD Analyst Consensus

7 analysts cover ZD: 0 strong buy, 3 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $49.29.

Common questions about ZD

What are ZD's key financials?
ZD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ZD recently traded at $42.41. Market cap is $1.52B. P/E ratio is 29.73. Revenue is $1.40B.
Is ZD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ZD. It does not provide personalized investment advice.
ZD

ZD